Primary graft dysfunction prevention strategies in the perioperative period
Every step of the transplant process is important in reducing the risk of PGD. Emerging machine perfusion technologies represent a promising advancement to enhance graft utilization, reduce PGD incidence, and improve overall outcomes following heart and lung transplantation.
Authors
- Suraj Yalamuri
- Adrien Bouglé (ORCID: https://orcid.org/0000-0002-8990-4705)
- Michael Cutrone
- Jérémie Guillemin (ORCID: https://orcid.org/0000-0003-3896-8802)
- Sharon L. McCartney (ORCID: https://orcid.org/0000-0002-5046-8504)
- Marcelo Arndt
Institutions
- Mayo Clinic (US)
- Duke University (US)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Pitié-Salpêtrière Hospital (FR)
- Duke Medical Center (US)
- Mayo Clinic in Florida (US)
- Groupe de recherche clinique en anesthésie réanimation médecine périopératoire (FR)
- Imation (United States) (US)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100413
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00